Objective response rate of placebo in randomized controlled trials of anticancer medicinesResearch in context

Autor: Arushi Sachdev, Isobel Sharpe, Meghan Bowman, Christopher M. Booth, Bishal Gyawali

Publikováno v: EClinicalMedicine, Vol 55, Iss , Pp 101753- (2023)

Summary: Background: Spontaneous regression of advanced solid tumors is infrequent but may occur. Quantifying response rates from placebo in cancer drug trials may provide important information for physicians, patients, and regulators. We aimed to pr

Externí odkaz: https://doaj.org/article/671bc2a67d954831b050efecd36ee359

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Objective response rate of placebo in randomized controlled trials of anticancer medicines.

Autor: Sachdev A; School of Medicine, Queen's University, Kingston, Canada., Sharpe I; Department of Public Health Sciences, Queen's University, Kingston, Canada., Bowman M; Department of Public Health Sciences, Queen's University, Kingston, Canada., Booth CM; Department of Public Health Sciences, Queen's University, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada.; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada., Gyawali B; Department of Public Health Sciences, Queen's University, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada.; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2022 Nov 24; Vol. 55, pp. 101753. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2023).